Bring the power of public radio to your classroom!

Image licensed under CC BY 2.0

Story Length: 4:11

Ebola: A Complex Virus to Cure

The Ebola outbreak in West Africa has inspired widespread fear throughout the U.S. and in many other countries. In reality, the threat of Ebola is actually quite small with only 1,700 deaths since 1976. The rarity of the Ebola virus has given major pharmaceutical companies very little incentive to develop a treatment for the virus given that the market for such a drug would be almost nonexistent. However, BioCryst Pharmaceuticals, a small pharmaceutical company based in Frederick, MD, has been given government help to develop a cure for the virus. Listen to learn more about the complexity of the Ebola virus and what is being done to develop a cure.

Story Length: 4:11

Listen to the Story:

SOURCE:

National Public Radio © 2014 National Public Radio, Inc. Used with the permission of NPR. All rights reserved.

04/11/2014


Listening Comprehension Questions

What makes Ebola such a complex virus?

Explain the economics of why big pharmaceutical companies have very little incentive to develop a drug which treats Ebola.

Is it fair that pharmaceutical companies avoid manufacturing drugs without major markets, despite the fact that people are in need of the drugs? Make the case for your argument using facts from the story.

Describe how BioCryst Pharmaceuticals tested the multiple strains of the virus in developing a potential drug.

Why might the government give pharmaceutical companies incentive to manufacture a drug to treat Ebola?


  • Listening Organizers

  • Fact, Question, Reponse
  • Fill-in-the-Blank
  • Language Identification Organizer